Bodilsen Jacob, Duerlund Lærke Storgaard, Mariager Theis, Brandt Christian Thomas, Petersen Pelle Trier, Larsen Lykke, Hansen Birgitte Rønde, Omland Lars Haukali, Tetens Malte Mose, Wiese Lothar, Jørgensen Rasmus Langelund, Leth Steffen, Nielsen Henrik
Department of Infectious Diseases, Aalborg University Hospital, 9000 Aalborg, Denmark.
Department of Pulmonary- and Infectious Diseases, Nordsjællands Hospital, 3400 Hillerød, Denmark.
Brain. 2023 Apr 19;146(4):1637-1647. doi: 10.1093/brain/awac312.
Studies on brain abscess are hampered by single-centre design with limited sample size and incomplete follow-up. Thus, robust analyses on clinical prognostic factors remain scarce. This Danish nationwide, population-based cohort study included clinical details of all adults (≥18 years) diagnosed with brain abscess in the Danish National Patient Registry from 2007 through 2014 and the prospective clinical database of the Danish Study Group of Infections of the Brain covering all Danish departments of infectious diseases from 2015 through 2020. All patients were followed for 6 months after discharge. Prognostic factors for mortality at 6 months after discharge were examined by adjusted modified Poisson regression to compute relative risks with 95% confidence intervals (CI). Among 485 identified cases, the median age was 59 years [interquartile range (IQR 48-67)] and 167 (34%) were female. The incidence of brain abscess increased from 0.4 in 2007 to 0.8 per 100 000 adults in 2020. Immuno-compromise was prevalent in 192/485 (40%) and the clinical presentation was predominated by neurological deficits 396/485 (82%), headache 270/411 (66%), and fever 208/382 (54%). The median time from admission until first brain imaging was 4.8 h (IQR 1.4-27). Underlying conditions included dental infections 91/485 (19%) and ear, nose and throat infections 67/485 (14%), and the most frequent pathogens were oral cavity bacteria (59%), Staphylococcus aureus (6%), and Enterobacteriaceae (3%). Neurosurgical interventions comprised aspiration 356/485 (73%) or excision 7/485 (1%) and was preceded by antibiotics in 377/459 (82%). Fatal outcome increased from 29/485 (6%) at discharge to 56/485 (12%) 6 months thereafter. Adjusted relative risks for mortality at 6 months after discharge was 3.48 (95% CI 1.92-6.34) for intraventricular rupture, 2.84 (95% CI 1.45-5.56) for immunocompromise, 2.18 (95% CI 1.21-3.91) for age >65 years, 1.81 (95% CI 1.00-3.28) for abscess diameter >3 cm, and 0.31 (95% CI 0.16-0.61) for oral cavity bacteria as causative pathogen. Sex, neurosurgical treatment, antibiotics before neurosurgery, and corticosteroids were not associated with mortality. This study suggests that prevention of rupture of brain abscess is crucial. Yet, antibiotics may be withheld until neurosurgery, if planned within a reasonable time period (e.g. 24 h), in some clinically stable patients. Adjunctive corticosteroids for symptomatic perifocal brain oedema was not associated with increased mortality.
脑脓肿研究因单中心设计、样本量有限和随访不完整而受到阻碍。因此,对临床预后因素进行有力分析的研究仍然很少。这项基于丹麦全国人口的队列研究纳入了2007年至2014年在丹麦国家患者登记处诊断为脑脓肿的所有成年人(≥18岁)的临床细节,以及2015年至2020年丹麦脑感染研究小组覆盖丹麦所有传染病科室的前瞻性临床数据库。所有患者出院后随访6个月。通过调整后的修正泊松回归分析出院后6个月的死亡预后因素,以计算95%置信区间(CI)的相对风险。在485例确诊病例中,中位年龄为59岁[四分位间距(IQR 48 - 67)],167例(34%)为女性。脑脓肿发病率从2007年的每10万成年人0.4例增至2020年的每10万成年人0.8例。192/485例(40%)存在免疫功能低下,临床表现以神经功能缺损为主396/485例(82%)、头痛270/411例(66%)、发热208/382例(54%)。从入院到首次脑部成像的中位时间为4.8小时(IQR 1.4 - 27)。基础疾病包括牙科感染91/485例(19%)、耳鼻喉感染67/485例(14%),最常见的病原体为口腔细菌(59%)、金黄色葡萄球菌(6%)和肠杆菌科细菌(3%)。神经外科干预包括穿刺抽吸356/485例(73%)或切除7/485例(1%),459例中有377例(82%)在神经外科手术前使用了抗生素。出院时的死亡结局为29/485例(6%),6个月后增至56/485例(12%)。出院后6个月死亡的调整后相对风险为:脑室破裂为3.48(95% CI 1.92 - 6.34),免疫功能低下为2.84(95% CI 1.45 - 5.56),年龄>65岁为2.18(95% CI 1.21 - 3.91),脓肿直径>3 cm为1.81(95% CI 1.00 - 3.28),致病病原体为口腔细菌时为0.31(95% CI 0.16 - 0.61)。性别、神经外科治疗、神经外科手术前使用抗生素以及使用糖皮质激素与死亡率无关。本研究表明,预防脑脓肿破裂至关重要。然而,对于一些临床稳定的患者,如果能在合理时间内(如24小时)计划进行神经外科手术,抗生素可推迟使用。用于症状性病灶周围脑水肿的辅助性糖皮质激素与死亡率增加无关。